Oncotarget Spreads Knowledge of Cancer Strategies to the Medical and Scientific Worlds

Oncotarget serves an important function the medical research field. It covers research on all the aspects of oncology research. This peer-reviewed publication is a must have for all medical professional researching ways to combat the ravages of cancers attacking the human organism. The journal was first started in 2010 and is published by Impact Journals. Mikhail Blagosklonny and Andrei V. Gudkov are the editors-in-chief of this valuable weekly publication. The journal is peer reviewed and is published by Impact Journals.

There is a community of cancer researchers that is dedicated to finding cures and advancing the knowledge about cancer that is being discovered by different groups around the world. Efforts like Oncotarget serve to advance the fight against all types of cancers by spreading knowledge through the medical community. The information contained within the pages of Oncotarget is targeted at scientists and researchers, and not for the general public. The level of information is at a very advanced stage and is undecipherable by the general reading public. Oncotarget is also available on Dove Press.

Mikhail Blagosklonny was educated in Russia and currently is a professor of Oncology at the prestigious Roswell Park Cancer Institute in Buffalo, New York. He continues his quest for cures and treatments fighting cancer.

Andrei V. Gudkov shares the responsibility of this weekly cancer research edition. He also is working as a cancer researcher connected to the Roswell Park Cancer Institute in Buffalo.

These two valiant men are fighting the greatest enemy of man. Their efforts or those of their successors will eventually lead to the termination of cancers in the human body and will save countless suffering.